Cardiology

GE Breakthroughs Seek to Re-invent Cardiovascular Ultrasound

New features bring additional utility to the Vivid e and Vivid 7 Dimension

GE Healthcare recently launched two breakthroughs for its Vivid e and Vivid 7 Dimension cardiovascular ultrasound systems at the Annual Conference of Cardiological Society of India held in Hyderabad. Building upon GE's successful introduction of Vivid products in 2000, GE continues to bring to market quick, robust, high-performance and patient-friendly portable cardiovascular ultrasound system reaching out to more patients.

This introduction brings ultra-definition imaging enhancements to the true real-time 4D imaging of the Vivid 7 Dimension. It combines image acquisition and processing technology to take imaging to the next level for an optimal image with one-button control. The new ultra-definition clarity control feature combines multiple 2D settings that reduce noise, keeping edges smooth without destroying fine detail. It enables image personalisation for 4D, cardiac and vascular imaging.

"The understanding of depth in a live 3D-image, visualised on a 2D-screen, is essential but challenging," said Ganesh Prasad, Vice President, GE Healthcare Clinical Systems. With the two new features, Depth Colour Render and Stereo Vision, GE provides an excellent solution to overcome this limitation. Both new features support an intuitive impression of morphologic anatomic structures in a 3D image and therefore simplify interpretation and 3D navigation impressively.

As ultrasound machines become more compact and their image quality more precise, doctors have begun carrying the body-imaging technology to rural India. No longer is ultrasound available only to hospitals with reliable power supplies and room for bulky equipment. Cardiovascular disease is now a leading cause of death in rural India. There is a need to develop new healthcare services to address this huge new burden of chronic diseases.

V Raja, President and CEO, GE Healthcare, South Asia, added, "Echocardiography has long been recognised in the broader medical community as a valuable diagnostic test for the evaluation of cardiac structure and function. Since the echocardiogram is a non-invasive test and involves no medications, patient can immediately return to normal activities. GE Healthcare is developing innovative ultrasound systems to help address some of today's most pressing healthcare issues such as improving access to quality cardiac care in rural communities, shifting to an 'early health' model where technologies such as ultrasound can be used to help detect diseases earlier when they can be more effectively treated and in a cost effective manner."

EH News Bureau